Skip to main content

UPDATE 1-J&J results top estimates, takes $13.6 bln tax charge

Jan 23 (Reuters) - Johnson & Johnson reported adjusted quarterly profit and revenue slightly above analysts' expectations on Tuesday, as the healthcare company gained from strong demand for new drugs including cancer and psoriasis treatments.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.